TRCT
PALI icon

Tower Research Capital (TRC)’s Palisade Bio PALI Stock Holding History

Tower Research Capital (TRC)’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.2K Sell
12,081
-41,761
-78% -$82.2K ﹤0.01% 3342
2026
Q1 		$94.2K Buy
53,842
+52,817
+5,153% +$96K ﹤0.01% 2233
2025
Q4 		$2.41K Sell
1,025
-4,371
-81% -$8.4K ﹤0.01% 4538
2025
Q3 		$4.64K Buy
5,396
+829
+18% +$648 ﹤0.01% 4312
2025
Q2 		$3.11K Sell
4,567
-3
-0.1% -$2 ﹤0.01% 4549
2025
Q1 		$3.11K Sell
4,570
-116
-2% -$137 ﹤0.01% 4466
2024
Q4 		$7.73K Buy
4,686
+3,089
+193% +$8.13K ﹤0.01% 4050
2024
Q3 		$5.67K Buy
1,597
+859
+116% +$3.31K ﹤0.01% 4236
2024
Q2 		$3.32K Buy
+738
New +$4.03K ﹤0.01% 4905
2023
Q2 		– Sell
-165
Closed -$9K – 6278
2023
Q1 		$9K Buy
+165
New +$5.81K ﹤0.01% 4525
2022
Q4 		– Sell
-24
Closed -$2K – 6237
2022
Q3 		$2K Sell
24
-16
-40% -$3.39K ﹤0.01% 5594
2022
Q2 		$12K Buy
40
+33
+471% +$15.9K ﹤0.01% 4294
2022
Q1 		$5K Hold
7
– – ﹤0.01% 5087
2021
Q4 		$7K Buy
+7
New +$12.2K ﹤0.01% 4928
2021
Q3 		– Sell
-1
Closed -$4K – 6052
2021
Q2 		$4K Buy
+1
New +$4.54K ﹤0.01% 4829
2021
Q1 		– Sell
-9
Closed -$60.8K – 5202
2020
Q4 		$37K Buy
9
+4
+80% +$12K ﹤0.01% 3395
2020
Q3 		$12K Buy
+5
New +$16K ﹤0.01% 4026
2017
Q3 		– Hold
0
– – – 4056
2017
Q2 		– Hold
0
– – – 2109
2016
Q2 		– Hold
0
– -$2K – 4823
2016
Q1 		– Hold
0
– – – 3418
2015
Q4 		– Hold
0
– – – 3781
2015
Q3 		– Hold
0
– – – 2484
2015
Q2 		– Hold
0
– – – 2103
2014
Q4 		– Hold
0
– -$34K – 4511
2014
Q3 		– Hold
0
– – – 1860
2014
Q2 		– Hold
0
– – – 1670
2014
Q1 		– Hold
0
– – – 4187
2013
Q4 		– Hold
0
– – – 4816
2013
Q3 		– Hold
0
– – – 4756

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Tower Research Capital (TRC)'s PALI Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Palisade Bio (PALI) stake by 78% in Q2 2026, selling an estimated $82.2K and leaving 12,081 shares worth $25.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3342.

Tower Research Capital (TRC) first reported a position in PALI in Q3 2020 and has held it in 17 quarters since. The position peaked at $94.2K in Q1 2026. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Tower Research Capital (TRC) held 12,081 shares of Palisade Bio worth $25.2K as of Q2 2026.
  • Tower Research Capital (TRC) sold 41,761 Palisade Bio shares in Q2 2026, an estimated $82.2K.
  • Palisade Bio made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3342 holding.
  • Tower Research Capital (TRC) first reported a position in Palisade Bio in Q3 2020 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s Palisade Bio position peaked at $94.2K in Q1 2026.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.